Weekly docetaxel as second-line therapy in non-small cell lung cancer: a phase II study.
Rossi D, Graziano F, Ugolini M, Dennetta D, Alessandroni P, Catalano V, Giordani P, Fedeli SL, Fedeli A, Catalano G.
Rossi D, et al. Among authors: fedeli sl, fedeli a.
Tumori. 2004 Jan-Feb;90(1):50-3. doi: 10.1177/030089160409000112.
Tumori. 2004.
PMID: 15143972
Clinical Trial.